Key Takeaways Moderna reports Q3 2025 results on Nov. 6, with forecasts showing lower sales and wider losses.COVID-19 vaccine revenue is expected to fall sharply amid weaker demand for boosters.The CMV vaccine failure clouds Moderna's growth plans despite a strong cash position and broad pipeline.Moderna (MRNA) is set to report third-quarter 2025 earnings on Nov. 6, before the opening bell. The Zacks Consensus Estimate for sales and earnings is pegged at $860 million and a loss of $2.15 per share, respectiv ...

Moderna Inc (NASDAQ:MRNA) stock is trading sharply lower on Monday afternoon as recent clinical setbacks overshadowed positive pipeline news.MRNA stock is struggling to find support. Check out the latest moves here.What To Know: The decline continues despite Moderna’s announcement on Monday that it dosed the first patient in a Phase 1/2 study for mRNA-2808, its investigational T-cell engager for multiple myeloma.This positive step was tempered by the fallout from the company’s Oct. 23 update, when it announ ...

CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the Company's investigational mRNA-based T-cell engager (TCE) for participants with relapsed or refractory multiple myeloma (RRMM). The first dose was administered at SCRI Oncology Partners in Nashville, Tennessee, in collaboration with Sarah Cannon Research Institute (SCRI). ...

If you'd like to learn more about how to best position yourself in under valued stocks mispriced by the market to end October, consider joining Out Fox The Street .Stone Fox Capital is an RIA from Oklahoma. Mark Holder is a CPA with degrees in Accounting and Finance. He is also Series 65 licensed and has 30 years of investing experience, including 15 years as a portfolio manager. Mark leads the investing group Out Fox The Street where he shares stock picks and deep research to help readers uncover potential ...

While many investors focus on semiconductors and AI or the growth sector, one of my Economic Modern Family members has been busy.The Biotech Sector ETF (NASDAQ: IBB), has made new multi-year highs. We cannot say new all-time highs as that was made in 2021 during Covid.However, we can discount that unusual time and safely say the Biotech Sector ETF (IBB) is on a tear and could very well continue. Sign up for our FREE newsletter and receive our best trading ideas and research Leave this field empty ...

美股周五早盘，莫德纳(MRNA)股价下跌4.1%，部分回吐了昨日高达13.9%的涨幅。周四有报道称，该 公司正与至少一家大型制药商就潜在的收购交易进行谈判，推动当天该股飙升。 来源：视频滚动新闻 ...

股价表现与驱动因素 - 莫德纳公司股价在最近一个交易日大幅上涨13.9%，收于28.14美元，此次上涨伴随显著放量 [1] - 股价上涨的驱动因素是数份报告显示莫德纳正与一家大型制药公司就潜在的大型合作或收购协议进行战略谈判 [1] - 此次上涨与该公司股价在过去四周累计下跌10.5%形成对比 [1] 公司财务业绩预期 - 市场预期莫德纳在即将公布的季度报告中每股亏损为2.15美元，较去年同期变化-7266.7% [2] - 预期季度收入为8.6007亿美元，较去年同期下降53.8% [2] - 在过去30天内，对该季度的共识每股收益预期被下调了5.8% [3] 同业公司表现 - 同业公司Septerna, Inc. 在上一交易日下跌2.1%，收于21.49美元，但过去一个月累计上涨15.5% [3] - Septerna, Inc. 即将公布报告的共识每股收益预期在过去一个月维持在0.19美元不变，较去年同期增长102.3% [4] - 莫德纳与Septerna, Inc. 同属Zacks医疗-生物医学和遗传学行业，且两家公司目前的Zacks评级均为3（持有）[3][4]

港股市场表现与驱动因素 - 中国中冶前三季度营业收入3350.94亿元，同比减少18.79%，归属于上市公司股东的净利润39.7亿元，同比减少41.88% [1] - 福森药业全资附属公司研发的"恩扎卢胺软胶囊"上市申请获国家药监局批准 [1] - 三花智控前三季度营业收入240.29亿元，同比增长16.86%，归属于上市公司股东的净利润32.42亿元，同比增长40.85% [1] - 荣昌生物前三季度营业收入约17.2亿元，同比增长42.27%，归属于上市公司股东的净亏损约5.51亿元，同比收窄48.6% [1] - 新特能源前三季度归属于上市公司股东的净亏损人民币5.26亿元 [1] - 春立医疗前三季度营业收入7.56亿元，同比增长48.75%，归属于上市公司股东的净利润1.92亿元，同比增长213.21% [2] - 信达生物2025年第三季度总产品收入超人民币33亿元，同比保持约40%增长 [2] - 龙蟠科技前三季度营业收入约58.25亿元，同比增长2.91%，归属于上市公司股东的净亏损约1.1亿元，同比收窄63.53% [2] - 三生制药与辉瑞达成交易，涉及12.50亿美元预付款及48亿美元里程碑付款 [2] - 中国中车前三季度营业收入约1838.65亿元，同比增长20.49%，归属于上市公司股东的净利润约99.64亿元，同比增长37.53% [2] 美股市场表现与驱动因素 - Carvana第三季度整体收入同比增长54.5%至56.5亿美元，高于分析师预期的50.8亿美元 [3] - 谷歌第三季度营收首破1000亿美元，全年资本开支指引超出预期，AI需求强劲带动云业务提速，订单积压达1550亿美元 [3][4] - Meta Platforms第三季度营收为512亿美元，同比大增26%，净利润为27亿美元，远低于预期，主要因确认159.3亿美元一次性税务支出 [4] - 比特币概念股普跌，包括Strategy跌近7%，Coinbase跌超5%，Circle跌超6%等 [4] - eBay第三季度销售额同比增长9%至28.2亿美元，超过市场预期，但股价创下二十多年来最大跌幅 [4] - 康卡斯特2025年第三季度流失10.4万名家庭宽带用户，连续第十个季度出现用户下滑 [5] - CoreWeave收购Core Scientific的要约被股东否决 [5] - Roblox第三季度营收为14亿美元，同比增长48%，净亏损2.574亿美元，比上年同期扩大 [5] - Moderna股价上涨，因有消息称公司已与至少一家大型制药商就大规模交易进行收购谈判 [5] - 奥驰亚第三季度净收入下降1.7%至52.5亿美元，可燃产品销量下降8.0%，口腔烟草产品销量下降9.6% [6]

Meta CEO Mark Zuckerberg on stage at the Meta Connect conference in September. David Paul Morris / Bloomberg via Getty Images Close Key Takeaways Shares of a social media juggernaut slumped as investors balked at its rapidly accelerating spending on artificial intelligence, while reports of potential partnership or buyout talks helped a vaccine maker's shares shoot higher. Chipotle Mexican Grill (CMG) stock fell 18.2%, the most of any S&P 500 component, after the fast-casual burrito chain reported lower-tha ...

智通财经APP获悉，周四，Moderna(MRNA.US)股价走高，截至发稿，该股涨超9%，报26.95美元。消 息面上，一位熟悉讨论情况的人士透露，该公司已与至少一家大型制药商就一项大规模交易进行收购谈 判。 ...